Literature DB >> 8088198

Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer.

Q S Li1, S H Cao, G M Xie, Y H Gan, H J Ma, J Z Lu, Z H Zhang.   

Abstract

In the evaluation of Chinese herbs (A), ear-acupuncture (B) and epidural morphine (C) to relieve postoperative pain and abdominal distension, sixteen male patients with primary liver cancer were observed. This study was conducted by means of orthogonal experiment and double blind, randomized design. The patients received various treatments according to the display of the orthogonal table L16(2)15 which corresponds to 2(3) factorial experiment design. C+ (morphine 2 mg) was given before the peritoneum was sutured. A+ (orally administered) and B+ were given 24 hours after operation. 50-100 mg of pethidine was given when the pain intensity VAS (0-100) exceeded 50-70. The observation parameters included plasma leucine enkephalin (LEK), postoperative total dosage of narcotics administered for 5 days, VAS for pain and pain reliever, abdominal distension, urinary retention, constipation, etc. The results were as follows: a. Patients who had received A (A+B+C+, A+B+C-, A+B-C-, A+B-C+); C (C+A+B+, C+A+B-, C+A-B+, C+A-B-), or B (B+A+C+, B+A+C-, B+A-C+, B+A-C-) produced better analgesic effects than those who had received placebo. The A, B, and C reduced narcotics 650, 450 and 550 mg respectively when compared with placebo. The effects of A and C were of statistical significance (P < 0.05), while AB, BC, and AC interactions were not found; b. A and B minimized abdominal distension and urinary retention, while C prolonged them. As compared with the placebo, A and B accelerated restoration of bowel peristalsis (P < 0.05, ANOVA). Both A and B decreased it for 165 hours, while epidural morphine prolonged it for 49 hours; and c.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088198

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gary N Asher; Daniel E Jonas; Remy R Coeytaux; Aimee C Reilly; Yen L Loh; Alison A Motsinger-Reif; Stacey J Winham
Journal:  J Altern Complement Med       Date:  2010-10       Impact factor: 2.579

Review 2.  Oral morphine for cancer pain.

Authors:  Philip J Wiffen; Bee Wee; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-04-22

Review 3.  Systematic review of acupuncture in cancer care: a synthesis of the evidence.

Authors:  M Kay Garcia; Jennifer McQuade; Robin Haddad; Sonya Patel; Richard Lee; Peiying Yang; J Lynn Palmer; Lorenzo Cohen
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

4.  Electroacupuncture for postoperative pain and gastrointestinal motility after laparoscopic appendectomy (AcuLap): study protocol for a randomized controlled trial.

Authors:  Gangmi Kim
Journal:  Trials       Date:  2015-10-14       Impact factor: 2.279

5.  Effectiveness of acupuncture for the treatment of postoperative pain: A protocol for a systematic review of randomized controlled trial.

Authors:  Qinhong Zhang; Jin-Huan Yue; Zhong-Ren Sun; Brenda Golianu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

6.  Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Chuihua Sun; Fang Dong; Ting Xiao; Wenni Gao
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 7.  Acupuncture-Point Stimulation for Postoperative Pain Control: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Xian-Liang Liu; Jing-Yu Tan; Alex Molassiotis; Lorna K P Suen; Yan Shi
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-12       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.